STORY OF OUR FIRM

Saturday, July 19, 2008

Clinical Trials for Mesothelioma Patients: Early Diagnosis Study Criteria for Asbestos Workers in Canada

Read about the study criteria for a current clinical trial being conducted to study early diagnosis factors in asbestos workers diagnosed with mesothelioma or lung cancer. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Toronto, Canada.

Recruitment Information:
Recruitment Status: Recruiting
Enrollment: 1,000
Study Start Date: March 2005
Estimated Study Completion Date: March 2010

Study Population: prior exposure to asbestos and or documented pleural plaques

Inclusion Criteria:
prior asbestos exposure at least 20 years ago and/or documented pleural plaques (chest x-ray evidence)
Resident of Ontario, Canada

Exclusion Criteria:
prior cancer (except non-melanotic skin cancer)

Courtesy of ClinicalTrials.gov,

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma & Asbestosis Mortalities Across the US: 1979-2001 (c/o EWG)

“We have seen first-hand how asbestos has wreaked havoc on Americans working in naval shipyards, automobile plants, and the construction industry. Most often this is through their employers’ conscious choice for profits over a worker's health.”

-- Joseph Patrick Williams, a trial attorney in the Asbestos Litigation department of Weitz & Luxenberg

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
	Mesothelioma Home Page
	Mesothelioma: An Overview
	The Clock Is Ticking
	Our Toughest Cases
	Diagnosis
	Symptoms, Stages, Treatment
	Latest News
	New York Numbers
	Asbestos
IN THIS SECTION Antineoplaston therapy for mesothelioma patients Antineoplaston trial for mesothelioma patients Antineoplaston clinical trial for mesothelioma Antineoplaston therapy for mesothelioma patients Antineoplaston test for mesothelioma patients AZD2171 therapy for mesothelioma patients AZD2171 trial for mesothelioma patients AZD2171 trial for mesothelioma disease Mesothelioma patient study of AZD2171 effects AZD2171 therapy for mesothelioma patients Contact info for mesothelioma AZD2171 facilities Current Bortezomib therapy for mesothelioma Bortezomib trial description for mesothelioma Outcomes of Bortezomib against mesothelioma cancer Criteria of Bortezomib study on mesothelioma test Effects of Bortezomib trial on mesothelioma cancer Bortezomib therapy for mesothelioma patients Current Dasatinib therapy for mesothelioma NSC 732517 trial description for mesothelioma NSC 732517 trial for mesothelioma patients Eligibility for mesothelioma trial of NSC 732517 Mesothelioma patient profile for NSC 732517 trial Mesothelioma therapy criteria to test NSC 732517 Information on NSC 732517 trial for mesothelioma Bortezomib therapy for mesothelioma patients Bortezomib and Cisplatin in mesothelioma trial Cisplatin therapy for mesothelioma patients Bortezomib and Cisplatin in mesothelioma trial Mesothelioma therapy criteria to test NSC 732517 Information on NSC 732517 trial for mesothelioma Current Imatinib therapy for mesothelioma patients Imatinib Mesylate trial for mesothelioma patients Outcomes of Imatinib against mesothelioma cancer Recruitment data to test Imatinib on mesothelioma Inclusion standard in Imatinib mesothelioma trial Exclusion standard in Imatinib mesothelioma trial Contact info for Imatinib mesothelioma study Current Immunotoxin therapy: mesothelioma patients Immunotoxin therapy for mesothelioma patients Objectives of Immunotoxin trial on mesothelioma Study outline for Immunotoxin mesothelioma trial Disease traits in Immunotoxin mesothelioma trial Patient traits: Immunotoxin mesothelioma trial Contact info for Immunotoxin mesothelioma program Early mesothelioma symptoms from Canada asbestos Canada study criteria of early mesothelioma traits Contact info for mesothelioma program in Canada Cisplatin and Pemetrexed therapy for mesothelioma Description of Pemetrexed mesothelioma study Inclusion standard in Pemetrexed mesothelioma test Exclusion standard in Pemetrexed mesothelioma test Contact info for Pemetrexed mesothelioma study NGR for mesothelioma NGR drug trials against mesothelioma NGR for mesothelioma study Exclusion criteria for mesothelioma NGR study Contact for Antineoplaston test on mesothelioma Pazopanib for mesothelioma patients Pazopanib for mesothelioma study Pazopanib inclusion criteria at mesothelioma trial Patient criteria for mesothelioma Pazopanib study Pazopanib for mesothelioma therapy Pemetrexed drug for mesothelioma patients Pemetrexed drug study for mesothelioma patients Pemetrexed and cisplatin for mesothelioma patients Pemetrexed study outline for mesothelioma patients Pemetrexed disodium drug trial for mesothelioma Pemetrexed trials for mesothelioma patients Pemetrexed trials for mesothelioma patients Contact info: Pemetrexed trial for mesothelioma Vitamin B12 test on mesothelioma patients Vitamin B12 study on mesothelioma patients Outcome of Vitamin B12 on mesothelioma patients Vitamin B12 outline for mesothelioma study Patient criteria for B12 study on mesothelioma Criteria of Vitamin B12 therapy on mesothelioma Contact info of mesothelioma clinical trial of B12 Novartis LBH589 for mesothelioma Novartis LBH589 for mesothelioma study LBH589 trial for mesothelioma Clinical LBH589 for mesothelioma Clinical trial for esophageal cancer, mesothelioma Clinical trial of hTNF for mesothelioma Valproate for Mesothelioma Vandetanib tested for mesothelioma Vorinostat tested for mesothelioma RETURN BACK TO Mesothelioma Symptoms, Stages, Treatment of Mesothelioma Treatment

see also: Vitamin B12 test on mesothelioma patients Clinical trial to study Vitamin B12 effect on mesothelioma patients Clinical trial to judge effect of Vitamin B12 on mesothelioma patients Information on NSC 732517 trial for mesothelioma Information on program to treat mesothelioma patients with NSC 732517 Contact information on mesothelioma clinical trial with NSC 732517 Clinical trials on asbestos illness: mesothelioma Info about clinical trials on mesothelioma, an asbestos illness Information on clinical trials of the asbestos illness, mesothelioma

Name	Phone	Email

Do you have a legal question? Ask us! strictly confidential

Your Question